Home Tools
Log in
Cart

Search Result

Search Results for " humanized "

20

Compounds

Cat No. Product Name Synonyms Targets
T77448 Naxitamab Naxitamab-gqgk,Humanized 3F8,Hu3F8 Others
Naxitamab (Hu3F8) is a humanized monoclonal antibody against GD2 (hu3F8). Naxitamab has antitumor activity and can be used to study neuroblastoma, osteosarcoma, and other GD2-positive cancers.
T9915 Eculizumab Complement System
Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5
T9926 Omalizumab Others
Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE)
T9912 Trastuzumab EGFR
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastr...
T9911 Tocilizumab Interleukin
Tocilizumab (anti-IL-6R) is a humanized monoclonal antibody that binds to the interleukin-6 receptor
T9924 Obinutuzumab Obinutuzumab/afutuzumab Others
Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma.
T9962 Mepolizumab SB 240563 IL Receptor
Mepolizumab (SB 240563) is a humanized monoclonal antibody neutralizing IL-5. Mepolizumab can be used in studies about severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
T9922 Matuzumab EGFR
Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associated with the growth of blood vessels in malignancy facilitating tumor growth and survival.
T76790 Inotuzumab Others
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. Inotuzumab is a naked antibody to Inotuzumab ozogamicin and can be used to synthesize antibody-active molecule conjugator...
T77480 Bivatuzumab BIWA 4 Others
Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
T9253 CPFX4158 Antibacterial
CPFX4158 is a mannose deriviative and an antibacterial agent that is potentially useful in transgenic humanized- CEACAM6 mouse.
T77099 Nimacimab JNJ 2463,RYI-018 Others
Nimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis.
T76888 Quetmolimab E-6011,KANAb 001 Others
Quetmolimab is a humanized monoclonal antibody targeting chemokine ligand 1 (CX3CL1) that can be used to study rheumatoid arthritis.
T77399 Crizanlizumab ADAKVEO,SEG-101 Others
Crizanlizumab (Adakveo) is a humanized monoclonal antibody against P-selectin for the prevention of pain crises in sickle cell disease.
T76975 Tomaralimab OPN-305 TLR
Tomaralimab (OPN-305) is a humanized IgG4 monoclonal antibody targeting TLR2. Tomarlimab is used to study myelodysplastic syndromes (MDS).
T9904 Bevacizumab VEGFR
Bevacizumab, a humanized monoclonal antibody, specifically and with high affinity binds to all isoforms of VEGF-A.
T9914 Vedolizumab Integrin
Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of Crohn's disease and ulcerative colitis.
T77118 Plozalizumab MLN-1202 CCR
Plozalizumab (MLN-1202) is a humanized selective and potent anti-CCR2 antibody.Plozalizumab has antitumor activity.Plozalizumab is used in the study of malignant melanoma.
T76763 Teplizumab PRV-031,MGA-031 Others
Teplizumab (MGA-031) is a humanized monoclonal antibody against CD3 that slows the loss of beta cell function.Teplizumab is used to treat type 1 diabetes.
T77422 Lacutamab IPH 41,IPH 4102
Lacutamab (IPH 4102) is a potent and selective humanized anti-KIR3DL2 antibody.Lacutamab has potential anticancer activity for the study of leukemia and lymphoma.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
TargetMol